In a research report issued after close, RBC analyst Mark Mahaney reiterated an Outperform rating on Netflix (NASDAQ:NFLX) with a price target of …
Has Abercrombie & Fitch (NYSE: ANF) passed its heyday among high school students? The retail chain used to be crowded with adolescents shopping for …
In a research report published today, William Blair analyst Jason Ader reiterated an Outperform rating on Mobileye N.V.
In a research report sent to investors today, Cowen analyst Boris Peaker maintained an Outperform rating on Idera (NASDAQ:IDRA), while no price target …
Cowen analyst Ritu Baral maintained an Outperform rating on Avanir Pharmaceuticals (NASDAQ:AVNR) with a $20 price target, following the news that the company has entered …
In a research report sent to investors today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Neostem (NASDAQ:NBS) with a price …
In a research report published today, Roth Capital analyst Krishna Shankar maintained a Buy rating on InvenSense (NYSE:INVN) with a $25 price target, which …
Wedbush analyst Zarak Khurshid maintained an Outperform rating on Illumina (NASDAQ:ILMN) with a $200 price target, following the release of GenomeWeb article entitled, “Undercover …
In a research report sent to investors today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) and raised his …
Maxim Group analyst Jason Kolbert maintained a Buy rating on OncoSec Medical (OTC:ONCS) with a price target of $3.00, as the company announced a …
